Mesenchymal Stem Cell-Derived Extracellular Vesicle Therapy for Stroke: Challenges and Progress.

Area of Science:

• Regenerative Medicine
• Neuroscience
• Biotechnology

Background:

• Stroke is a primary cause of adult disability.
• Mesenchymal stem cells (MSCs) secrete factors like extracellular vesicles (EVs) that aid brain repair.
• EVs are cell-derived vesicles with therapeutic potential.

Purpose of the Study:

• To review recent advances in MSC-derived EV therapy for stroke.
• To highlight the potential of EVs as an alternative to stem cell infusion for stroke treatment.

Main Methods:

• Review of preclinical studies and clinical trials on MSC-derived EV therapy for stroke.
• Analysis of EV characteristics, function, and biogenesis.
• Comparison of EV therapy advantages over traditional stem cell therapy.

Main Results:

• MSC-derived EVs administered intravenously improve neurological outcomes in stroke models.
• EVs promote neurogenesis, angiogenesis, and neuroprotection.
• EV therapy offers advantages like improved biodistribution and a cell-free approach.

Conclusions:

• MSC-derived EV therapy is a rapidly advancing and promising strategy for stroke patients.
• EVs present unique benefits over cell-based therapies, including safety and practicality.
• Further research is essential to fully realize the therapeutic potential of EVs in stroke.